Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib

2016 ◽  
Vol 6 (3) ◽  
pp. 280-291 ◽  
Author(s):  
Peter N. Morcos ◽  
Yumi Cleary ◽  
Elena Guerini ◽  
Georgina Dall ◽  
Katrijn Bogman ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Drug Interactions ◽  
Cytochrome P450 3A ◽  
Alk Inhibitor ◽  
Clinical Drug

scholarly journals Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin

2014 ◽  
Vol 77 (6) ◽  
pp. 1039-1050 ◽  
Author(s):  
Spencer Y. Ling ◽  
Robert B. Huizinga ◽  
Patrick R. Mayo ◽  
Richard Larouche ◽  
Derrick G. Freitag ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Drug Interactions ◽  
Cytochrome P450 3A ◽  
P Glycoprotein

scholarly journals Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir

2011 ◽  
Vol 39 (6) ◽  
pp. 1070-1078 ◽  
Author(s):  
Brian J. Kirby ◽  
Ann C. Collier ◽  
Evan D. Kharasch ◽  
Dale Whittington ◽  
Kenneth E. Thummel ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Drug Interactions ◽  
Protease Inhibitors ◽  
Hiv Protease ◽  
Hiv Protease Inhibitors ◽  
Cytochrome P450 3A ◽  
Complex Drug
Sign in / Sign up

Export Citation Format

Share Document